Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Idera Pharmaceuticals stock

Learn how to easily invest in Idera Pharmaceuticals stock.

Idera Pharmaceuticals Inc is a biotechnology business based in the US. Idera Pharmaceuticals shares (IDRA) are listed on the NASDAQ and all prices are listed in US Dollars. Idera Pharmaceuticals employs 32 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Idera Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IDRA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Idera Pharmaceuticals stock price (NASDAQ: IDRA)

Use our graph to track the performance of IDRA stocks over time.

Idera Pharmaceuticals shares at a glance

Information last updated 2022-01-17.
Latest market close$0.59
52-week range$0.51 - $6.14
50-day moving average $0.69
200-day moving average $0.99
Wall St. target price$1.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.10

Buy Idera Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Idera Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Idera Pharmaceuticals price performance over time

Historical closes compared with the close of $0.59 from 2022-01-21

1 week (2022-01-18) -11.52%
1 month (2021-12-23) -2.70%
3 months (2021-10-25) -32.22%
6 months (2021-07-23) -43.81%
1 year (2021-01-25) -90.13%
2 years (2020-01-24) -68.45%
3 years (2019-01-25) 2.72
5 years (2017-01-25) 1.47

Idera Pharmaceuticals financials

Gross profit TTM $-16,707,000
Return on assets TTM -52.91%
Return on equity TTM 88.57%
Profit margin 0%
Book value $0.63
Market capitalisation $34.5 million

TTM: trailing 12 months

Idera Pharmaceuticals share dividends

We're not expecting Idera Pharmaceuticals to pay a dividend over the next 12 months.

Have Idera Pharmaceuticals's shares ever split?

Idera Pharmaceuticals's shares were split on a 1:8 basis on 29 July 2018. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Idera Pharmaceuticals shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Idera Pharmaceuticals shares which in turn could have impacted Idera Pharmaceuticals's share price.

Idera Pharmaceuticals share price volatility

Over the last 12 months, Idera Pharmaceuticals's shares have ranged in value from as little as $0.51 up to $6.14. A popular way to gauge a stock's volatility is its "beta".

IDRA.US volatility(beta: 1.59)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Idera Pharmaceuticals's is 1.5879. This would suggest that Idera Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Idera Pharmaceuticals overview

Idera Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Frequently asked questions

What percentage of Idera Pharmaceuticals is owned by insiders or institutions?
Currently 21.819% of Idera Pharmaceuticals shares are held by insiders and 11.79% by institutions.
How many people work for Idera Pharmaceuticals?
Latest data suggests 32 work at Idera Pharmaceuticals.
When does the fiscal year end for Idera Pharmaceuticals?
Idera Pharmaceuticals's fiscal year ends in December.
Where is Idera Pharmaceuticals based?
Idera Pharmaceuticals's address is: 505 Eagleview Boulevard, Exton, PA, United States, 19341
What is Idera Pharmaceuticals's ISIN number?
Idera Pharmaceuticals's international securities identification number is: US45168K4058
What is Idera Pharmaceuticals's CUSIP number?
Idera Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 44860M108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site